NAD+observational2023

Improved Yield for the Enzymatic Synthesis of Radiolabeled Nicotinamide Adenine Dinucleotide.

ACS bio & med chem Au

confidence

Key findings

Improved enzymatic synthesis of 32P-NAD+ with 98% yield; highest reported yield for enzymatic NAD+ synthesis; method versatile for labels and derivatives.

View source on PubMed (PMID 36820310) ↗

Sample size
Not reported
Population
Not applicable (methodology paper)
Dosing
Not reported
Duration
Not reported
Route
Not reported
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

Labeled β-nicotinamide adenine dinucleotide (NAD) analogues have been critical for uncovering new biochemical connections and quantitating enzymatic activity. They function as tracers for enzymology, flux analyses, and in situ measurements. Nevertheless, there is limited availability of specific types of analogues, especially radiolabeled NAD isotopologues. Here, we describe an improved enzymatic synthesis reaction for 32P- NAD+ with a yield of 98% ± 1%, using lowered concentrations of reactants and standard equipment. This represents the highest reported yield for the enzymatic synthesis of NAD+ to date. With the high yield we were able to directly use the reaction product to generate derivatives, such as 32P-NADP. The high-yield enzymatic synthesis is versatile for a broad variety of labels and NAD derivatives. Its advantages include lowered concentrations of reactants, providing sufficient amounts of product for downstream applications, and minimizing intermediate purification steps.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.